Display options
Share it on

Int J Cardiol Heart Vasc. 2019 Jul 10;24:100396. doi: 10.1016/j.ijcha.2019.100396. eCollection 2019 Sep.

Endogenously released adenosine causes pulmonary vasodilation during the acute phase of pulmonary embolization in dogs.

International journal of cardiology. Heart & vasculature

Hiroko Takahama, Hiroshi Asanuma, Osamu Tsukamoto, Shin Ito, Masafumi Kitakaze

Affiliations

  1. Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.
  2. Department of Cell Biology, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.
  3. Department of Molecular Imaging in Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan.
  4. Department of Internal Medicine, Meiji University of Integrative Medicine, Hiyoshicho, Nantan, Kyoto, Japan.
  5. Department of Medical Biochemistry, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan.

PMID: 31334333 PMCID: PMC6620623 DOI: 10.1016/j.ijcha.2019.100396

Abstract

BACKGROUND: Endogenous adenosine levels increase under stress in various organs. Exogenously administered adenosine is a well-known pulmonary vasodilator. However, the physiology and therapeutic potential of endogenous adenosine during alteration in pulmonary hemodynamics such as pulmonary embolism is not elucidated. We hypothesized that the adenosine level increases following an acute elevation of pulmonary resistance, resulting in pulmonary vasodilation.

METHODS: We induced acute pulmonary embolization by injecting plastic beads in anesthetized dogs. Plasma adenosine levels, defined as the product of plasma adenosine concentration and simultaneous cardiac output, were assessed from blood samples from the superior vena cava, main pulmonary artery (MPA), and ascending aorta 1 and 10 min following injection. Hemodynamics were assessed with (

RESULTS: Mean pulmonary arterial pressure (PAP) increased from 11 ± 1 mmHg, peaking at 28 ± 4 mmHg at 52 ± 13 s after injection. During this period, total pulmonary resistance (TPR) elevated from 11 ± 1 to 33 ± 6 Wood unit. Plasma adenosine levels increased in the MPA from 14.5 ± 2 to 38.8 ± 7 nmol/min 1 min after injection. TPR showed greater elevation under 8SPT treatment, to 96 ± 12 Wood unit at PAP peak.

CONCLUSIONS: Endogenously released adenosine after acute pulmonary embolization is one of the initial pulmonary vasodilators. The immediate surge in plasma adenosine levels in the MPA could lead to a hypothesis that adenosine is released by the right heart in response to pressure overload.

Keywords: Adenosine; Hemodynamics; Pulmonary embolization; Vasodilation

Conflict of interest statement

Drs. Takahama, Asanuma, Tsukamoto, Ito have no conflict of interest. Kitakaze reports grants and personal fees from Takeda, during the conduct of the study; grants from Japanese government, grants fro

References

  1. Chest. 2002 Mar;121(3):877-905 - PubMed
  2. Physiology (Bethesda). 2009 Oct;24:298-306 - PubMed
  3. Am J Physiol. 1995 May;268(5 Pt 2):H1862-8 - PubMed
  4. Am J Physiol. 1975 Dec;229(6):1625-31 - PubMed
  5. Nat Med. 2011 Jan;17(1):79-86 - PubMed
  6. Pharmacol Ther. 2013 Oct;140(1):92-111 - PubMed
  7. Life Sci. 1981 Jun 8;28(23):2631-41 - PubMed
  8. Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1633-40 - PubMed
  9. Crit Care Med. 2013 Jul;41(7):e118-24 - PubMed
  10. Cardiovasc Res. 2000 Oct;48(1):23-33 - PubMed
  11. J Mol Med (Berl). 2013 Feb;91(2):183-93 - PubMed
  12. Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1731-7 - PubMed
  13. J Mol Cell Cardiol. 2000 Mar;32(3):345-54 - PubMed
  14. Am J Physiol. 1984 Oct;247(4 Pt 2):H541-7 - PubMed
  15. Circulation. 1991 Sep;84(3):1145-9 - PubMed
  16. J Thromb Haemost. 2009 Sep;7(9):1597-9 - PubMed
  17. Am J Physiol. 1994 Feb;266(2 Pt 2):H521-30 - PubMed
  18. Circulation. 2006 Sep 26;114(13):1417-31 - PubMed
  19. Clin Chem. 1992 Feb;38(2):256-62 - PubMed
  20. J Clin Invest. 1992 Mar;89(3):909-18 - PubMed
  21. J Mol Cell Cardiol. 1978 Mar;10(3):293-300 - PubMed
  22. Compr Physiol. 2012 Jan;2(1):711-41 - PubMed
  23. Blood. 2004 Dec 15;104(13):3986-92 - PubMed
  24. Pharmacol Ther. 2001 Aug;91(2):133-47 - PubMed
  25. Pulm Pharmacol Ther. 2012 Feb;25(1):48-54 - PubMed
  26. Shock. 2008 Feb;29(2):197-204 - PubMed
  27. Med Hypotheses. 2009 Jun;72(6):713-9 - PubMed
  28. J Am Coll Cardiol. 2009 Jul 28;54(5):375-85 - PubMed
  29. Blood. 2008 Feb 15;111(4):2024-35 - PubMed
  30. Am J Cardiol. 1997 Jun 19;79(12A):2-10 - PubMed
  31. Circulation. 1995 Feb 1;91(3):838-44 - PubMed
  32. Am J Physiol. 1998 Nov;275(5):H1663-72 - PubMed
  33. Am J Physiol. 1992 Jul;263(1 Pt 1):L73-8 - PubMed
  34. Ann Biomed Eng. 2014 Aug;42(8):1631-43 - PubMed
  35. Nat Rev Drug Discov. 2013 Apr;12(4):265-86 - PubMed
  36. J Appl Physiol (1985). 1989 May;66(5):2079-83 - PubMed
  37. J Immunol. 2007 Jun 15;178(12):8127-37 - PubMed
  38. Eur Heart J. 2008 Sep;29(18):2276-315 - PubMed
  39. Am J Physiol. 1989 Apr;256(4 Pt 1):C799-806 - PubMed
  40. Am J Physiol. 1982 Jan;242(1):H24-9 - PubMed
  41. J Appl Physiol (1985). 2010 Nov;109(5):1307-17 - PubMed
  42. Am J Physiol. 1996 Jan;270(1 Pt 2):H200-7 - PubMed
  43. Crit Care Med. 2011 Dec;39(12):2700-4 - PubMed
  44. Pharmacol Ther. 2008 Sep;119(3):242-63 - PubMed
  45. Circulation. 2006 Jul 11;114(2):e28-32 - PubMed

Publication Types